Non-Interventional Registry Study to Evaluate the Effectiveness of TheraSphere® in the Treatment of Hepatocellular Carcinoma (HCC)

NCT04069468 · clinicaltrials.gov ↗

COMPLETED

Status

1247

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DEVICE: TheraSphere

Sponsor

Boston Scientific Corporation

Collaborators

[object Object]